NORMAL PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS AT LONG-TERM FOLLOW-UP AFTER JEJUNOILEAL BYPASS-SURGERY IN MORBIDLY OBESE INDIVIDUALS

被引:22
作者
SYLVAN, A
RUTEGARD, JN
JANUNGER, KG
SJOLUND, B
NILSSON, TK
机构
[1] UMEA UNIV HOSP,DEPT CLIN CHEM,S-90185 UMEA,SWEDEN
[2] ORNSKOLDSVIK HOSP,DEPT SURG,ORNSKOLDSVIK,SWEDEN
[3] UMEA UNIV HOSP,DEPT SURG,S-90185 UMEA,SWEDEN
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1992年 / 41卷 / 12期
关键词
D O I
10.1016/0026-0495(92)90110-V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Forty-five patients who had been subjected to jejuno-ileal bypass (JIB) surgery for morbid obesity and 10 obese nonsurgery subjects were studied. The former group was examined 14 to 20 years ffter surgery, and was found to have lower mean plasminogen activator inhibitor type 1 (PAI-1) activity (8.4 v 32 U/mL, P < .001), tissue plasminogen activator (tPA) antigen concentrations (7.2 v 12 μg/L, P < .01), body mass index (BMI), and fasting plasma insulin, triglyceride, and cholesterol levels. The PAI-1 levels were correlated with BMI, waist to hip ratio, and insulin, triglyceride, and cholesterol levels. Thus, previously obese subjects have normal PAI levels 14 to 20 years after treatment with JIB surgery, in contrast to the high PAI-1 levels in nonsurgery obese subjects. © 1992.
引用
收藏
页码:1370 / 1372
页数:3
相关论文
共 11 条
[1]   EFFECT OF PARTIAL ILEAL BYPASS-SURGERY ON MORTALITY AND MORBIDITY FROM CORONARY HEART-DISEASE IN PATIENTS WITH HYPERCHOLESTEROLEMIA - REPORT OF THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERLIPIDEMIAS (POSCH) [J].
BUCHWALD, H ;
VARCO, RL ;
MATTS, JP ;
LONG, JM ;
FITCH, LL ;
CAMPBELL, GS ;
PEARCE, MB ;
YELLIN, AE ;
EDMISTON, WA ;
SMINK, RD ;
SAWIN, HS ;
CAMPOS, CT ;
HANSEN, BJ ;
TUNA, N ;
KARNEGIS, JN ;
SANMARCO, ME ;
AMPLATZ, K ;
CASTANEDAZUNIGA, WR ;
HUNTER, DW ;
BISSETT, JK ;
WEBER, FJ ;
STEVENSON, JW ;
LEON, AS ;
CHALMERS, TC .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :946-955
[2]  
CHMIELEWSKA J, 1986, CLIN CHEM, V32, P482
[3]  
DOLAN G, 1988, Fibrinolysis, V2, P26
[4]  
FRANCIS JL, 1988, FIBRINOGEN FIBRIN ST
[5]  
JANSSON JH, 1991, CLINICAL ASPECTS OF FIBRINOLYSIS, P95
[6]   INCREASED PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS - A POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND ATHEROTHROMBOSIS [J].
JUHANVAGUE, I ;
ALESSI, MC ;
VAGUE, P .
DIABETOLOGIA, 1991, 34 (07) :457-462
[7]  
NILSSON P, 1991, CLINICAL ASPECTS OF FIBRINOLYSIS, P131
[8]  
RANBY M, 1986, CLIN CHEM, V32, P2160
[9]   FIBRINOLYTIC VARIABLES ARE RELATED TO AGE, SEX, BLOOD-PRESSURE, AND BODY BUILD MEASUREMENTS - A CROSS-SECTIONAL STUDY IN NORSJO, SWEDEN [J].
SUNDELL, IB ;
NILSSON, TK ;
RANBY, M ;
HALLMANS, G ;
HELLSTEN, G .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (08) :719-723
[10]   REDUCTION OF ELEVATED PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS DURING MODEST WEIGHT-LOSS [J].
SUNDELL, IB ;
DAHLGREN, S ;
RANBY, M ;
LUNDIN, E ;
STENLING, R ;
NILSSON, TK .
FIBRINOLYSIS, 1989, 3 (01) :51-53